Michael Song
Director, CMC Upstream Process Development Janux Therapeutics
Seminars
Thursday 25th June 2026
Chair’s Closing Remarks
4:00 pm
Thursday 25th June 2026
Advancing Bispecific & Multi-Specific T-Cell Engagers to Maximize Tumor-Specific Engagement for More Potent Therapeutics
